Renovaro Biosciences Inc.

Renovaro Biosciences Inc.verified

RENB

Price:

$0.3268

Market Cap:

$56.25M

Renovaro Biosciences Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), and cancer in the United States. The company's product pipeline includes RENB-HV-01 for autologous HIV curative treatment; RENB-HV-12, a therapeutic HIV vaccine; and RENB-HB-01, a gene therapy curative treatment for HBV. It also develops RENB-DC-11, an allogeneic dendritic cell therapeutic vaccine for pancreatic cancer; RENB-DC-12-XX, an allogeneic dendritic cell therapeutic vaccine for other solid tumors; and RENB-HV-21 for treating HIV with allogeneic n...[Read more]

Industry

Biotechnology

IPO Date

2018-02-07

Stock Exchange

NASDAQ

Ticker

RENB

The PE Ratio as of May 2025 (TTM) for Renovaro Biosciences Inc. (RENB) is -1.31

According to Renovaro Biosciences Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.31. This represents a change of -104.80% compared to the average of 27.26 of the last 4 quarters.

Renovaro Biosciences Inc. (RENB) Historical PE Ratio (quarterly & annually)

How has RENB PE Ratio performed in the past?

The mean historical PE Ratio of Renovaro Biosciences Inc. over the last ten years is -13.51. The current -1.31 PE Ratio has changed 869.61% with respect to the historical average. Over the past ten years (40 quarters), RENB's PE Ratio was at its highest in in the March 2025 quarter at 116.53. The PE Ratio was at its lowest in in the September 2018 quarter at -152.14.

Quarterly (TTM)
Annual

Average

-13.51

Median

-10.42

Minimum

-33.77

Maximum

-0.80

Renovaro Biosciences Inc. (RENB) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Renovaro Biosciences Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 131.58%

Maximum Annual PE Ratio = -0.80

Minimum Annual Increase = -97.62%

Minimum Annual PE Ratio = -33.77

Quarterly (TTM)
Annual
YearPE RatioChange
2024-1.86131.58%
2023-0.80-10.05%
2022-0.89-89.81%
2021-8.77-48.66%
2020-17.0983.79%
2019-9.30-19.45%
2018-11.54-65.83%
2017-33.774.20%
2016-32.4173.67%
2014-18.66-97.62%

Renovaro Biosciences Inc. (RENB) Average PE Ratio

How has RENB PE Ratio performed in the past?

The current PE Ratio of Renovaro Biosciences Inc. (RENB) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-1.19

5-year avg

-5.88

10-year avg

-13.51

Renovaro Biosciences Inc. (RENB) PE Ratio vs. Peers

How is RENB’s PE Ratio compared to its peers?

Renovaro Biosciences Inc.’s PE Ratio is

CompanyPE RatioMarket cap

Build a custom stock screener for Renovaro Biosciences Inc. (RENB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Renovaro Biosciences Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Renovaro Biosciences Inc. (RENB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Renovaro Biosciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Renovaro Biosciences Inc.'s PE Ratio?

How is the PE Ratio calculated for Renovaro Biosciences Inc. (RENB)?

What is the highest PE Ratio for Renovaro Biosciences Inc. (RENB)?

What is the 3-year average PE Ratio for Renovaro Biosciences Inc. (RENB)?

What is the 5-year average PE Ratio for Renovaro Biosciences Inc. (RENB)?

How does the current PE Ratio for Renovaro Biosciences Inc. (RENB) compare to its historical average?